In addition, it was observed that the treatment of immunodeficient mice bearing a human breast cancer with an adenoviral vector containing the MMP9 gene (AdMMP9) inhibited tumor growth and neoangiogenesis by inducing massive neutrophil infiltration into the cancer tissue, which resulted in an enhanced antitumor immune response [134]. The gene discussed is MMP9; the disease is breast carcinoma.